Melanoma immunotherapy by targeted IL-2 depends on CD4+ T-cell help mediated by CD40/CD40L interaction
J. Clin. Invest. Holger N. Lode, et al. 105:1623
doi:10.1172/JCI9177 [Go to this article.]

Problems with a PDF?